Clinical Trials Browser

Graft vs Host Disease × blinatumomab × 90 days × Clear all

NCT07297914 2025-12-22

FORUM2

Phase 2/3 Not yet recruiting

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma